For nearly two decades, Apex HealthCare Consulting has provided strategic advice and guidance to the pharmaceutical and biotech sectors. We have worked with over 100 companies, on 700 projects, across 40 therapy areas, tailoring our services to the individual needs and profiles of our clients. This experience means we are expertly placed to work with businesses in the sector keen to take advantage of the opportunities presented by the pricing and access changes taking place in the USA and particularly Europe. We offer 5 key services: • Strategic Investment Advice Based on our experience of the sector we provide advice to ensure you have the knowledge and background research to make the right choices on funding rounds, trade-sales or investment decisions. • Market Access Support Working with a range of stakeholders including payers, purchasers and key opinion leaders across Europe and the USA, we manage projects that offer strategic market access consultancy, pricing market research and joint regulatory/market access advice. • Commercial Forecasting We provide dashboard based forecast & valuation models for our clients to use in-house. Each model is created based on individual client needs and is driven by appropriate sector dynamics. • Business Development Support Evidence-based due diligence evaluation is essential for individual products and company acquisitions. We carry out 3-4 major due diligence projects per year producing detailed recommendations as well as independent forecasts where required. • In-House Asset Support Company go-no-go development decisions must be based on input from clinical and development experts across a range of disease areas. We carry out interviews with a range of experts to ensure our clients have all the data to make the best business decisions. Client Base We work at senior management/board level with: • Academic spin-outs and start-ups • Emerging & established mid-cap companies • Investment teams.